Close this search box.

National Cancer Research Institute (NCRI) to close – Kidney Cancer UK

The National Cancer Research Institute (NCRI) has announced that it will be winding down its operations prior to shutting down altogether.

In a letter to colleagues, Fiona Driscoll Chair of the NCRI, said that the decision had been taken reluctantly and was due (at least in part) to the impact of uncertainty in the wider economic and research environment. The NCRI is a charitable organisation primarily funded by the NCRI Partners. It does not receive any Government funding.

To read a copy of the letter from Fiona Driscoll please click HERE.

This is a serious blow to research across all forms of cancer and throughout the UK. The scale of such research is enormous, a part of which benefits people with kidney cancer. “It is vital for the UK to take a coordinated approach to clinical research. This has been one of the many achievements by the NCRI for which we are grateful,” said CEO of Kidney Cancer UK, Malcolm Packer.

Chair of the Bladder and Renal Group of the NCRI, Professor Rob Jones, said: “This is going to leave a large hole in the UK’s approach to cancer research, which must be addressed urgently.”

Patients involved in clinical trials will not be affected by this development and they should continue to participate fully. If any patients do have concerns, they should contact their clinical team.

<img decoding="async" src="" alt="Malcolm Packer“>

Malcolm is Chief Executive Officer at Kidney Cancer UK and Kidney Cancer Scotland and has worked with the charity in various capacities for over 15 years.